Leveraging Electronic Health Record (EHR) Tools to Reduce Health Disparities for Patients With Uncontrolled Hypertension
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT05030467
- Status
- Completed
Conditions
- Blood Pressure
- Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- REDUCE-BP Intervention — BEHAVIORALPre-visit: Providers in the intervention arm will receive dashboards which will highlight racial/ethnic differences in rates of achieving blood pressure control within their patient panel. The dashboard will also provide individual-level information for patients with poorly controlled blood pressure. During visit: Providers will receive clinical decision support within relevant patients' charts that highlight the patient's under-treated blood pressure and potential impacts of social needs. Providers will have the opportunity to provide enhanced patient education materials, which can be automatically ordered within the clinical decision support. Post-visit: Patient-subjects' access to the online patient portal will be streamlined by the inclusion of information about the patient portal in the patients' after-visit summary. Providers will also be able to referral patients automatically to nurse BP visits.
Study Details
A two-arm cluster randomized controlled trial targeting primary care providers will be conducted to evaluate the impact of a multicomponent electronic health record (EHR) intervention on hypertension management. Given the cluster trial design, randomization will be conducted at the site level, and in the intervention sites, all eligible providers will receive the intervention. The intervention consists of enhancing tools already available to primary care providers in the EHR system, including developing and implementing provider disparities dashboards, enhancing electronic decision support, and simplifying self-monitoring orders and communication materials. The intervention aims to improve blood pressure control and reduce health disparities in racial and ethnic minorities. Findings from this trial will provide important insight into whether a multicomponent intervention targeting providers and leveraging health information technology can reduce health disparities.
Key Dates
- Start date
- May 3, 2022
- Status verified
- May 2025
- Primary completion
- May 3, 2024
- Completion
- Jun 1, 2024
Study Design
- Enrollment
- 49,210 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Intervention ArmProviders within the clinics randomized to the intervention arm will receive a variety of EHR-based tools for eligible patients with uncontrolled hypertension.
- No Intervention: Control ArmProviders within the clinics randomized to usual care will receive no EHR tools, except those currently available in clinical practice.
Primary Outcome Measure
Change in Systolic Blood Pressure [ Time Frame: 12 months ]
Locations (1)
| Facility | City | State | ZIP |
|---|---|---|---|
| Advocate Health Care | Chicago | Illinois | 60515 |
Find similar trials in Chicago, IL
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Community Intervention to Reduce CardiovascuLar Disease in ChicagoRecruiting · Northwestern University · Chicago, Illinois
- Church-based Intervention to Improve Blood Pressure in African AmericansRecruiting · Rush University Medical Center · Chicago, Illinois